149 related articles for article (PubMed ID: 30977389)
21. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
[TBL] [Abstract][Full Text] [Related]
22. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
23. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.
Oliveira C; Bordin MC; Grehan N; Huntsman D; Suriano G; Machado JC; Kiviluoto T; Aaltonen L; Jackson CE; Seruca R; Caldas C
Hum Mutat; 2002 May; 19(5):510-7. PubMed ID: 11968083
[TBL] [Abstract][Full Text] [Related]
24. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
[TBL] [Abstract][Full Text] [Related]
25. Familial lobular breast cancer: Is testing for germline CDH1 mutations necessary?
Corso G; Sacchini V; Pravettoni G; Veronesi P; Bonanni B
Eur J Surg Oncol; 2019 Oct; 45(10):1760-1761. PubMed ID: 31350074
[No Abstract] [Full Text] [Related]
26. E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer.
Oliveira C; Pinheiro H; Figueiredo J; Seruca R; Carneiro F
Prog Mol Biol Transl Sci; 2013; 116():337-59. PubMed ID: 23481202
[TBL] [Abstract][Full Text] [Related]
27. Hereditary gastric cancer: what's new? Update 2013-2018.
van der Post RS; Oliveira C; Guilford P; Carneiro F
Fam Cancer; 2019 Jul; 18(3):363-367. PubMed ID: 30989426
[TBL] [Abstract][Full Text] [Related]
28. E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer.
Corso G; Pedrazzani C; Pinheiro H; Fernandes E; Marrelli D; Rinnovati A; Pascale V; Seruca R; Oliveira C; Roviello F
Eur J Cancer; 2011 Mar; 47(4):631-9. PubMed ID: 21106365
[TBL] [Abstract][Full Text] [Related]
29. Hereditary diffuse gastric cancer syndrome: improved performances of the 2015 testing criteria for the identification of probands with a CDH1 germline mutation.
Benusiglio PR; Colas C; Rouleau E; Uhrhammer N; Romero P; Remenieras A; Moretta J; Wang Q; De Pauw A; Buecher B; Stoppa-Lyonnet D; Mouret-Fourme E; Noguès C; Di Maria M; Tlemsani C; Warcoin M; Grandjouan S; Malka D; Caron O; Blayau M
J Med Genet; 2015 Aug; 52(8):563-5. PubMed ID: 26025002
[No Abstract] [Full Text] [Related]
30. Clinical and functional characterization of the CDH1 germline variant c.1679C>G in three unrelated families with hereditary diffuse gastric cancer.
Pena-Couso L; Perea J; Melo S; Mercadillo F; Figueiredo J; Sanches JM; Sánchez-Ruiz A; Robles L; Seruca R; Urioste M
Eur J Hum Genet; 2018 Sep; 26(9):1348-1353. PubMed ID: 29769627
[TBL] [Abstract][Full Text] [Related]
31. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C
N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427
[TBL] [Abstract][Full Text] [Related]
32. Genetic screening for hereditary diffuse gastric cancer.
Oliveira C; Seruca R; Caldas C
Expert Rev Mol Diagn; 2003 Mar; 3(2):201-15. PubMed ID: 12647996
[TBL] [Abstract][Full Text] [Related]
33. Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family.
Roviello F; Corso G; Pedrazzani C; Marrelli D; De Falco G; Berardi A; Garosi L; Suriano G; Vindigni C; De Stefano A; Leoncini L; Seruca R; Pinto E
Eur J Surg Oncol; 2007 May; 33(4):448-51. PubMed ID: 17126523
[TBL] [Abstract][Full Text] [Related]
34. Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer.
Stone J; Bevan S; Cunningham D; Hill A; Rahman N; Peto J; Marossy A; Houlston RS
Br J Cancer; 1999 Apr; 79(11-12):1935-7. PubMed ID: 10206317
[TBL] [Abstract][Full Text] [Related]
35. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
[TBL] [Abstract][Full Text] [Related]
37. Germline mutations and polymorphic variants in MMR, E-cadherin and MYH genes associated with familial gastric cancer in Jiangsu of China.
Zhang Y; Liu X; Fan Y; Ding J; Xu A; Zhou X; Hu X; Zhu M; Zhang X; Li S; Wu J; Cao H; Li J; Wang Y
Int J Cancer; 2006 Dec; 119(11):2592-6. PubMed ID: 16929514
[TBL] [Abstract][Full Text] [Related]
38. Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer.
Xie ZM; Li LS; Laquet C; Penault-Llorca F; Uhrhammer N; Xie XM; Bignon YJ
Cancer; 2011 Jul; 117(14):3112-7. PubMed ID: 21271559
[TBL] [Abstract][Full Text] [Related]
39. A multidisciplinary approach allows identification of a new pathogenic CDH1 germline missense mutation in a hereditary diffuse gastric cancer family.
Betés M; Alonso-Sierra M; Valentí V; Patiño A
Dig Liver Dis; 2017 Jul; 49(7):825-826. PubMed ID: 28487081
[No Abstract] [Full Text] [Related]
40. CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions.
Herrera-Pariente C; Bonjoch L; Muñoz J; Fernàndez G; Soares de Lima Y; Mahmood R; Cuatrecasas M; Ocaña T; Lopez-Prades S; Llargués-Sistac G; Domínguez-Rovira X; Llach J; Luzko I; Díaz-Gay M; Lazaro C; Brunet J; Castillo-Manzano C; García-González MA; Lanas A; Carrillo M; Hernández San Gil R; Quintero E; Sala N; Llort G; Aguilera L; Carot L; Diez-Redondo P; Jover R; Ramon Y Cajal T; Cubiella J; Castells A; Balaguer F; Bujanda L; Castellví-Bel S; Moreira L
Gastric Cancer; 2024 Jul; 27(4):747-759. PubMed ID: 38796558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
